{"id":418428,"date":"2024-10-20T06:20:58","date_gmt":"2024-10-20T06:20:58","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-23-30441405-dc\/"},"modified":"2024-10-26T11:51:00","modified_gmt":"2024-10-26T11:51:00","slug":"bsi-23-30441405-dc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-23-30441405-dc\/","title":{"rendered":"BSI 23\/30441405 DC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 3 Terms and definitions 4 General principles 4.1 Type tests <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 4.2 General 5 Volatile organic substance emissions 5.1 General 5.2 Acceptance criteria <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 5.3 Test method <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 5.4 Assessment of exposure dose <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 6 Reporting <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | Annex\u20acA (informative) Rationale and guidance <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | Annex\u20acB (informative) Reference to the IMDRF essential principles and labelling guidances <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | Annex\u20acC (informative) Reference to the essential principles <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | Annex\u20acZA (informative) Relationship between this European standard and the General Safety and Performance Requirements of Regulation (EU) 2017\/745 aimed to be covered <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | Bibliography <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | Terminology \u2014 Alphabetized index of defined terms <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" BS EN ISO 18562-3 Biocompatibility evaluation of breathing gas pathways in healthcare applications – Part 3. Tests for emissions of volatile organic substances<\/b><\/p>\n |